至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.

Sci Rep. 2018-09; 
LiChong,CaoJing,ZhangNing,TuMeiqing,XuFengwei,WeiShuang,ChenXiaojing,XuYu
Products/Services Used Details Operation
Gene Synthesis … Method and Materials Plasmid. The expression plasmid pcDNA3.1 with CMV promoter from GenScript (Nanjing) was used to con- struct EMC2 (NM_014673.4)-RSPO2 (NM_178565.4) fusion gene, containing EMC2-RSPO2 fusion or RSPO2 … Get A Quote

摘要

Cancers are driven by a variety of somatic gene mutations and identifying these mutations enables the development of novel target drugs. We have sought to identify abnormalities in Wnt pathway-related genes that are sensitive to Wnt inhibitor treatment. We examined Patient Derived Xenograft (PDX) RNA samples and found new R-Spondin 2 (RSPO2) transcript fusions with the EMC2, PVT1 or HNF4G genes. These fusion events were identified in about 1.4% of the digestive system cancer samples. We then examined the oncogenic effects of the RSPO2-EMC2 fusion gene and confirmed that it can drive oncogenesis, sustain tumor growth and promote metastasis. Finally, we used a Wnt pathway Porcupine inhibitor CGX1321 to trea... More

关键词